Advertisement

Topics

Biotech startup developing carbon monoxide poisoning antidote closes $5M Series A

05:00 EDT 11 May 2018 | MedCity News

The Tus Science & Technology Service Group, an enterprise group in China, led the Series A round with participation from the commercialization arm of University of Pittsburgh Medical Center — UPMC Enterprises. 

Original Article: Biotech startup developing carbon monoxide poisoning antidote closes $5M Series A

NEXT ARTICLE

More From BioPortfolio on "Biotech startup developing carbon monoxide poisoning antidote closes $5M Series A"

Advertisement
Quick Search
Advertisement
Advertisement